ArticleVaccines2022

Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222.

Shu-Hsing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.